# Alcon acquires Tear Film Innovations for dry eye device

Alcon, a division of Novartis, has acquired Tear Film Innovations, Inc., manufacturer of the iLux Device for treating Meibomian Gland Dysfunction. The deal expands Alcon's dry eye portfolio.

- Type: Acquisition
- Announced: 2018-12-19
- Where: United States
- Status: completed
- Products: iLux Device for dry eye treatment
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Alcon Group](https://endata.com/companies/16712.md) (acquirer)
- [Tear Film Innovations, Inc.](https://endata.com/companies/36270.md) (target)

## Sources

- [novartis.com](https://www.novartis.com/news/media-releases/alcon-announces-acquisition-tear-film-innovations-inc), 2018-12-19: "With the acquisition of Tear Film, we're excited to bring this latest innovation to treat the millions of people around the world who suffer from dry eye."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.